Ocumension Therapeutics (FRA:5DG) Days Payable : 59.90 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Ocumension Therapeutics Days Payable?

Ocumension Therapeutics's average Accounts Payable for the six months ended in Dec. 2023 was €2.57 Mil. Ocumension Therapeutics's Cost of Goods Sold for the six months ended in Dec. 2023 was €7.84 Mil. Hence, Ocumension Therapeutics's Days Payable for the six months ended in Dec. 2023 was 59.90.

The historical rank and industry rank for Ocumension Therapeutics's Days Payable or its related term are showing as below:

FRA:5DG' s Days Payable Range Over the Past 10 Years
Min: 127.79 Med: 1081.58 Max: 72983.41
Current: 522.12

During the past 6 years, Ocumension Therapeutics's highest Days Payable was 72983.41. The lowest was 127.79. And the median was 1081.58.

FRA:5DG's Days Payable is ranked better than
75.63% of 714 companies
in the Biotechnology industry
Industry Median: 147.95 vs FRA:5DG: 522.12

Ocumension Therapeutics's Days Payable declined from Dec. 2022 (77.42) to Dec. 2023 (59.90). It may suggest that Ocumension Therapeutics accelerated paying its suppliers.

Ocumension Therapeutics Days Payable Historical Data

The historical data trend for Ocumension Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocumension Therapeutics Days Payable Chart

Ocumension Therapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

92,710.00

1,412.90

122.12

85.39

86.01

Ocumension Therapeutics Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial						37.50	57.04	77.42	83.74	59.90

Competitive Comparison of Ocumension Therapeutics's Days Payable

For the Biotechnology subindustry, Ocumension Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ocumension Therapeutics's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ocumension Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Ocumension Therapeutics's Days Payable falls into.

Ocumension Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Ocumension Therapeutics's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (2.939	+	3.235)	/	2 )	/	13.1	*	365
=	3.087					/	13.1	*	365
=	86.01

Ocumension Therapeutics's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (1.909	+	3.235)	/	2 )	/	7.836	*	365 / 2
=	2.572					/	7.836	*	365 / 2
=	59.90

Ocumension Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of Ocumension Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Ocumension Therapeutics (FRA:5DG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocumension Therapeutics (FRA:5DG) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

01477:Hong Kong

Address

No. 1858 Yinzhongnan Road, Guoxiang Subdistrict, Wuzhong District, Suzhou, Jiangsu, CHN

Website

http://www.ocumension.com

Ocumension Therapeutics is an ophthalmic pharmaceutical platform company identifying, developing, and commercializing ophthalmic therapies. It provides a pharmaceutical total solution to address unmet ophthalmic medical needs in China. Its product candidates include OT-401 (YUTIQ), OT-101, OT-301 (NCX 470), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-202, OT-503 (NCX 4251), OT-701, Ou Qin, Brimonidine tartrate eye drop, 0.5% moxifloxacin eye drop, OT-601-C, OT-302, OT-1301, T-1601, and OT-1602.

Ocumension Therapeutics (FRA:5DG) Headlines

No Headlines